Review:
Post Marketing Surveillance (pharmacovigilance)
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
Post-marketing surveillance, also known as pharmacovigilance, is the process of monitoring the safety and efficacy of pharmaceutical products after they have been approved and are on the market. It involves collecting, analyzing, and responding to data concerning adverse drug reactions (ADRs), medication errors, and other safety issues to ensure ongoing patient safety and optimal therapeutic outcomes.
Key Features
- Continuous monitoring of drug safety post-approval
- Collection and analysis of adverse event reports from healthcare providers, patients, and manufacturers
- Detection of rare or long-term side effects not identified during clinical trials
- Implementation of risk management strategies and updates to prescribing information
- Regulatory compliance with agencies like the FDA, EMA, and WHO
- Use of advanced data analytics and signal detection methods
- Enhancement of public health by minimizing drug-related risks
Pros
- Enhances patient safety by identifying hidden or rare adverse effects
- Supports regulatory decision-making and updates product information as needed
- Encourages continuous improvement in pharmaceutical quality and safety
- Facilitates transparency and accountability within the healthcare system
Cons
- Can be resource-intensive and require significant investment in monitoring infrastructure
- Potential delays in detecting rare adverse events due to underreporting or incomplete data
- Regulatory differences across countries may complicate global pharmacovigilance efforts
- Data privacy concerns associated with patient information collection